TREA

88035450 - IMMUNOSCAPE

Follow

Information

  • Trademark
  • 88035450
  • Serial Number
    88035450
  • Registration Number
    6039731
  • Filing Date
    July 12, 2018
    6 years ago
  • Registration Date
    April 28, 2020
    4 years ago
  • Transaction Date
    September 08, 2024
    6 months ago
  • Status Date
    April 28, 2020
    4 years ago
  • Published for Opposition Date
    February 11, 2020
    5 years ago
  • Location Date
    April 28, 2020
    4 years ago
  • First Use Anywhere Date
    March 01, 2017
    8 years ago
  • First Use In Commerce Date
    March 01, 2017
    8 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HETZEL, DANNEAN
  • Attorney Docket Number
    49741-460721
    Attorney Name
    Jon Jekel
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
IMMUNOSCAPE
Case File Statements
  • GS0421: Research and development services in the field of biotechnology; Research and development services in the field of immune profiling; research and development services in the field of immunotherapy; biotechnology services, namely, probing for multiple T cell specificities identification of tumor antigen-specific T cells for the treatment of cancer; biotechnology services, namely, probing for multiple T cell specificities identification of viral antigen-specific T cells in the field of infectious diseases; biotechnology services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; biotechnology services, namely, analysis by time-of-flight mass cytometry; research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; biotechnology services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system; consulting services in the field of biotechnology through the application of mass cytometry; Research and development services in the field of vaccines; research and development of immunotherapy products; research and development of vaccines for use in the field of immunotherapy; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; biotechnology services, namely, analysis by flow cytometry; consulting services in the field of vaccine research and development in the field of immunotherapies; platform as a service (PAAS) featuring computer software platforms for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of online non-downloadable computer software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of online non-downloadable computer software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features; providing temporary use of on-line non-downloadable cloud computing software for accessing, collecting, detecting, comparing, calculating, analyzing, displaying, transmitting, managing and storing immune profiling data; providing temporary use of on-line non-downloadable cloud computing software for use in performing lab services, describing the status of disease progression, prioritization of treatment strategies; providing temporary use of on-line non-downloadable cloud computing software for use in data collection, review, interpretation, comparison, and analysis of T cells and/or other immune cells features
Case File Event Statements
  • 4/16/2019 - 5 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/16/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/17/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/30/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/8/2018 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/8/2018 - 6 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/8/2018 - 6 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/15/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/15/2019 - 5 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/20/2019 - 5 years ago
    17 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 4/18/2019 - 5 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/18/2019 - 5 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/18/2019 - 5 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/19/2019 - 5 years ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/12/2019 - 5 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 11/19/2019 - 5 years ago
    15 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 11/20/2019 - 5 years ago
    16 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 11/20/2019 - 5 years ago
    18 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 11/22/2019 - 5 years ago
    19 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 12/3/2019 - 5 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/3/2019 - 5 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/5/2019 - 5 years ago
    22 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/5/2019 - 5 years ago
    24 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/5/2019 - 5 years ago
    23 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/30/2019 - 5 years ago
    25 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 1/7/2020 - 5 years ago
    26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/7/2020 - 5 years ago
    27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/8/2020 - 5 years ago
    28 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/22/2020 - 5 years ago
    29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/11/2020 - 5 years ago
    30 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/11/2020 - 5 years ago
    31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/28/2020 - 4 years ago
    32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/6/2022 - 2 years ago
    33 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/6/2022 - 2 years ago
    34 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/6/2022 - 2 years ago
    35 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/3/2024 - 6 months ago
    39 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 9/3/2024 - 6 months ago
    37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/3/2024 - 6 months ago
    36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/3/2024 - 6 months ago
    38 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA